Agios Pharmaceuticals Inc
NASDAQ:AGIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Agios Pharmaceuticals Inc
NASDAQ:AGIO
|
US |
|
Corporacion Acciona Energias Renovables SA
F:5BP
|
ES |
|
C
|
Campbell Soup Co
DUS:CSC
|
US |
|
C
|
Corning Inc
F:GLW
|
US |
|
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
|
US |
|
3
|
3M Co
XMUN:MMM
|
US |
|
Deliveroo PLC
LSE:ROO
|
UK |
|
Olam Group Ltd
SGX:VC2
|
SG |
|
UP Fintech Holding Ltd
NASDAQ:TIGR
|
CN |
|
C
|
CVS Health Corp
SWB:CVS
|
US |
|
Guillemot Corporation SA
F:GUL
|
FR |
|
InterContinental Hotels Group PLC
LSE:IHG
|
UK |
|
Paul Merchants Ltd
BSE:539113
|
IN |
Shareholder Yield
Current shareholder yield for AGIO is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AGIO Price
Agios Pharmaceuticals Inc
| Average Annual Return | -9.25% |
| Standard Deviation of Annual Returns | 33.79% |
| Max Drawdown | -72% |
| Market Capitalization | 1.7B USD |
| Shares Outstanding | 58 590 000 |
| Percentage of Shares Shorted | 11.85% |
